Trump, AstraZeneca Announce Deal to Lower US Drug Prices

Historic Drug Pricing Agreement

• 💡 President Trump announced a historic achievement to lower drug prices for Americans through a deal with AstraZeneca.
• 🎯 This agreement follows a similar pact with Pfizer, suggesting a framework for the White House's goal of reducing U.S. prescription medicine prices.
• 💰 The administration has been pressuring drugmakers to slash prices to match those paid in other developed nations, or face tariffs.

AstraZeneca's Commitments

• ✅ AstraZeneca, a major pharmaceutical manufacturer, committed to offering major discounts on its vast catalog of prescription drugs in the United States.
• 📈 The company will sell some medicines at a discount to the government's Medicaid health plan under a "Most Favored Nations" pricing clause, meaning the lowest price globally.
• 💊 Many of AstraZeneca's most popular drugs will also be listed online at TrumpRx.gov at heavily reduced, most favored nations costs.
• 📉 Significant price reductions are expected, with one example cited as a 654% reduction on inhalers for COPD and asthma, and certain diabetic medications.

Investment and Economic Impact

• 🚀 AstraZeneca will invest $50 billion in the United States over the next five years for research and development of new drugs.
• 🏭 This investment also includes onshoring manufacturing facilities across the country, such as a new plant in Charlottesville, Virginia, expected to create 3,600 jobs.
• 🇺🇸 This initiative is presented as a tremendous victory for American patients and the country, aiming to boost the US economy and create employment.

Administration's Stance on Healthcare Costs

• 🗣️ Trump stated that his administration is the first to substantially lower healthcare costs, achieving reductions that were previously thought impossible.
• 📊 He highlighted that while previous efforts might have yielded small percentage reductions, these new deals promise hundreds or even thousands of percent reductions in some cases.
• 💰 These price reductions are expected to have a huge impact on programs like Social Security, Medicare, and Medicaid by lowering prescription drug expenditures.